Literature DB >> 26107096

Pharmacotherapy: Quest for the quitting pill.

Cassandra Willyard.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26107096     DOI: 10.1038/522S53a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.

Authors:  Lawrence Toll; Nurulain T Zaveri; Willma E Polgar; Faming Jiang; Taline V Khroyan; Wei Zhou; Xinmin Simon Xie; Gregory B Stauber; Matthew R Costello; Frances M Leslie
Journal:  Neuropsychopharmacology       Date:  2012-01-25       Impact factor: 7.853

2.  Dynamic vaccine blocks relapse to compulsive intake of heroin.

Authors:  Joel E Schlosburg; Leandro F Vendruscolo; Paul T Bremer; Jonathan W Lockner; Carrie L Wade; Ashlee A K Nunes; G Neil Stowe; Scott Edwards; Kim D Janda; George F Koob
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

Review 3.  A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse.

Authors:  Linda P Dwoskin; Peter A Crooks
Journal:  Biochem Pharmacol       Date:  2002-01-15       Impact factor: 5.858

4.  Pharmacological stress is required for the anti-alcohol effect of the α3β4* nAChR partial agonist AT-1001.

Authors:  Andrea Cippitelli; Gloria Brunori; Kelly A Gaiolini; Nurulain T Zaveri; Lawrence Toll
Journal:  Neuropharmacology       Date:  2015-02-14       Impact factor: 5.250

5.  18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.

Authors:  S D Glick; M E Kuehne; I M Maisonneuve; U K Bandarage; H H Molinari
Journal:  Brain Res       Date:  1996-05-06       Impact factor: 3.252

6.  18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens.

Authors:  Olga D Taraschenko; Joseph M Shulan; Isabelle M Maisonneuve; Stanley D Glick
Journal:  Synapse       Date:  2007-07       Impact factor: 2.562

  6 in total
  11 in total

1.  Effectiveness of a Cocaine Hydrolase for Cocaine Toxicity Treatment in Male and Female Rats.

Authors:  Xirong Zheng; Ziyuan Zhou; Ting Zhang; Zhenyu Jin; Xiabin Chen; Jing Deng; Chang-Guo Zhan; Fang Zheng
Journal:  AAPS J       Date:  2017-11-27       Impact factor: 4.009

2.  Long-acting cocaine hydrolase for addiction therapy.

Authors:  Xiabin Chen; Liu Xue; Shurong Hou; Zhenyu Jin; Ting Zhang; Fang Zheng; Chang-Guo Zhan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

3.  Effects of a cocaine hydrolase engineered from human butyrylcholinesterase on metabolic profile of cocaine in rats.

Authors:  Xiabin Chen; Xirong Zheng; Ziyuan Zhou; Chang-Guo Zhan; Fang Zheng
Journal:  Chem Biol Interact       Date:  2016-05-03       Impact factor: 5.192

4.  Development of Fc-Fused Cocaine Hydrolase for Cocaine Addiction Treatment: Catalytic and Pharmacokinetic Properties.

Authors:  Xiabin Chen; Jing Deng; Wenpeng Cui; Shurong Hou; Jinling Zhang; Xirong Zheng; Xin Ding; Huimei Wei; Ziyuan Zhou; Kyungbo Kim; Chang-Guo Zhan; Fang Zheng
Journal:  AAPS J       Date:  2018-03-19       Impact factor: 4.009

5.  Structure-Based Design and Discovery of a Long-Acting Cocaine Hydrolase Mutant with Improved Binding Affinity to Neonatal Fc Receptor for Treatment of Cocaine Abuse.

Authors:  Fang Zheng; Xiabin Chen; Kyungbo Kim; Ting Zhang; Haifeng Huang; Shuo Zhou; Jinling Zhang; Zhenyu Jin; Chang-Guo Zhan
Journal:  AAPS J       Date:  2020-03-18       Impact factor: 4.009

6.  Reengineering of Albumin-Fused Cocaine Hydrolase CocH1 (TV-1380) to Prolong Its Biological Half-Life.

Authors:  Yingting Cai; Shuo Zhou; Zhenyu Jin; Huimei Wei; Linyue Shang; Jing Deng; Chang-Guo Zhan; Fang Zheng
Journal:  AAPS J       Date:  2019-11-21       Impact factor: 4.009

7.  Unexpected Reaction Pathway for butyrylcholinesterase-catalyzed inactivation of "hunger hormone" ghrelin.

Authors:  Jianzhuang Yao; Yaxia Yuan; Fang Zheng; Chang-Guo Zhan
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

8.  Clinical Potential of an Enzyme-based Novel Therapy for Cocaine Overdose.

Authors:  Ting Zhang; Xirong Zheng; Ziyuan Zhou; Xiabin Chen; Zhenyu Jin; Jing Deng; Chang-Guo Zhan; Fang Zheng
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

9.  Clinical potential of a rationally engineered enzyme for treatment of cocaine dependence: Long-lasting blocking of the psychostimulant, discriminative stimulus, and reinforcing effects of cocaine.

Authors:  Ting Zhang; Huimei Wei; Jing Deng; Fang Zheng; Chang-Guo Zhan
Journal:  Neuropharmacology       Date:  2020-07-22       Impact factor: 5.250

10.  Plant expression of cocaine hydrolase-Fc fusion protein for treatment of cocaine abuse.

Authors:  Guojun Wang; Ting Zhang; Haifeng Huang; Shurong Hou; Xiabin Chen; Fang Zheng; Chang-Guo Zhan
Journal:  BMC Biotechnol       Date:  2016-10-19       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.